BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24823795)

  • 1. Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stress.
    McDade SS; Patel D; Moran M; Campbell J; Fenwick K; Kozarewa I; Orr NJ; Lord CJ; Ashworth AA; McCance DJ
    Nucleic Acids Res; 2014 Jun; 42(10):6270-85. PubMed ID: 24823795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation.
    McDade SS; Henry AE; Pivato GP; Kozarewa I; Mitsopoulos C; Fenwick K; Assiotis I; Hakas J; Zvelebil M; Orr N; Lord CJ; Patel D; Ashworth A; McCance DJ
    Nucleic Acids Res; 2012 Aug; 40(15):7190-206. PubMed ID: 22573176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
    Si H; Lu H; Yang X; Mattox A; Jang M; Bian Y; Sano E; Viadiu H; Yan B; Yau C; Ng S; Lee SK; Romano RA; Davis S; Walker RL; Xiao W; Sun H; Wei L; Sinha S; Benz CC; Stuart JM; Meltzer PS; Van Waes C; Chen Z
    Oncogene; 2016 Nov; 35(44):5781-5794. PubMed ID: 27132513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.
    Chari NS; Ivan C; Le X; Li J; Mijiti A; Patel AA; Osman AA; Peterson CB; Williams MD; Pickering CR; Caulin C; Myers JN; Calin GA; Lai SY
    J Natl Cancer Inst; 2020 Mar; 112(3):266-277. PubMed ID: 31124563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C delta induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage.
    Liu H; Lu ZG; Miki Y; Yoshida K
    Mol Cell Biol; 2007 Dec; 27(24):8480-91. PubMed ID: 17938203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma.
    Bretz AC; Gittler MP; Charles JP; Gremke N; Eckhardt I; Mernberger M; Mandic R; Thomale J; Nist A; Wanzel M; Stiewe T
    Nucleic Acids Res; 2016 Apr; 44(7):3204-18. PubMed ID: 26819410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis.
    Schavolt KL; Pietenpol JA
    Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Modeling of TP63-TP53 Interaction and Rational Design of Inhibitors: Implications for Therapeutics.
    Ozdemir ES; Gomes MM; Fischer JM
    Mol Cancer Ther; 2022 Dec; 21(12):1846-1856. PubMed ID: 36190964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.
    Vasmatzis G; Johnson SH; Knudson RA; Ketterling RP; Braggio E; Fonseca R; Viswanatha DS; Law ME; Kip NS; Ozsan N; Grebe SK; Frederick LA; Eckloff BW; Thompson EA; Kadin ME; Milosevic D; Porcher JC; Asmann YW; Smith DI; Kovtun IV; Ansell SM; Dogan A; Feldman AL
    Blood; 2012 Sep; 120(11):2280-9. PubMed ID: 22855598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activity.
    Sammons MA; Zhu J; Drake AM; Berger SL
    Genome Res; 2015 Feb; 25(2):179-88. PubMed ID: 25391375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between p63 and p53 expression in Merkel cell carcinoma and corresponding abnormalities in TP63 and TP53: a study and a proposal.
    DeCoste RC; Carter MD; Pasternak S; Fleming KE; Gaston D; Legge A; Ly TY; Walsh NM
    Hum Pathol; 2021 Nov; 117():31-41. PubMed ID: 34391748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.
    Humphries LA; Godbersen JC; Danilova OV; Kaur P; Christensen BC; Danilov AV
    Br J Haematol; 2013 Dec; 163(5):590-602. PubMed ID: 24117128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy.
    Costanzo A; Pediconi N; Narcisi A; Guerrieri F; Belloni L; Fausti F; Botti E; Levrero M
    FEBS Lett; 2014 Aug; 588(16):2590-9. PubMed ID: 24983500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line.
    Supino R; Perego P; Gatti L; Caserini C; Leonetti C; Colantuono M; Zuco V; Carenini N; Zupi G; Zunino F
    Eur J Cancer; 2001 Nov; 37(17):2247-56. PubMed ID: 11677115
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Di-Iacovo N; Ferracchiato S; Pieroni S; Scopetti D; Castelli M; Piobbico D; Pierucci L; Gargaro M; Chiasserini D; Servillo G; Della-Fazia MA
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731819
    [No Abstract]   [Full Text] [Related]  

  • 16. TP63 gene in stress response and carcinogenesis: a broader role than expected.
    Petitjean A; Hainaut P; Caron de Fromentel C
    Bull Cancer; 2006 Dec; 93(12):E126-35. PubMed ID: 17182369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.
    Folk WP; Kumari A; Iwasaki T; Pyndiah S; Johnson JC; Cassimere EK; Abdulovic-Cui AL; Sakamuro D
    J Biol Chem; 2019 Apr; 294(14):5700-5719. PubMed ID: 30733337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DSCP1, a novel TP53-inducible gene, is upregulated by strong genotoxic stresses and its overexpression inhibits tumor cell growth in vitro.
    Hata T; Ogawa T; Yokoyama TA; Fukushige S; Horii A; Furukawa T
    Int J Oncol; 2004 Mar; 24(3):513-20. PubMed ID: 14767535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA surveillance protein SMG1 activates p53 in response to DNA double-strand breaks but not exogenously oxidized mRNA.
    Gewandter JS; Bambara RA; O'Reilly MA
    Cell Cycle; 2011 Aug; 10(15):2561-7. PubMed ID: 21701263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor protein p53 recruits human Sin3B/HDAC1 complex for down-regulation of its target promoters in response to genotoxic stress.
    Bansal N; Kadamb R; Mittal S; Vig L; Sharma R; Dwarakanath BS; Saluja D
    PLoS One; 2011; 6(10):e26156. PubMed ID: 22028823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.